Asp isotopes inc. and isobio, inc. announce series seed funding of isobio, inc. to advance innovative antibody-isotope conjugates (aicstm) for cancer treatment

- isobio, inc. (isobio) is a u.s.-based radiotherapeutic development company focused on developing a broad pipeline of mab-based radioisotope therapeutics, known as antibody-isotope conjugates (aics tm ), targeting both derisked and novel tumor antigens for patients in need of new cancer therapies.
ASPI Ratings Summary
ASPI Quant Ranking